- Home
- BMEA vs AKYA Comparison
BMEA vs AKYA Comparison
Compare BMEA & AKYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMEA
- AKYA
- Stock Information
- Founded
- BMEA 2017
- AKYA 2015
- Country
- BMEA United States
- AKYA United States
- Employees
- BMEA N/A
- AKYA N/A
- Industry
- BMEA Biotechnology: Pharmaceutical Preparations
- AKYA Medical Specialities
- Sector
- BMEA Health Care
- AKYA Industrials
- Exchange
- BMEA Nasdaq
- AKYA Nasdaq
- Market Cap
- BMEA 145.0M
- AKYA 145.5M
- IPO Year
- BMEA 2021
- AKYA 2021
- Fundamental
- Price
- BMEA $4.25
- AKYA $3.02
- Analyst Decision
- BMEA Buy
- AKYA Buy
- Analyst Count
- BMEA 13
- AKYA 7
- Target Price
- BMEA $27.92
- AKYA $4.40
- AVG Volume (30 Days)
- BMEA 831.0K
- AKYA 1.2M
- Earning Date
- BMEA 10-29-2024
- AKYA 03-03-2025
- Dividend Yield
- BMEA N/A
- AKYA N/A
- EPS Growth
- BMEA N/A
- AKYA N/A
- EPS
- BMEA N/A
- AKYA N/A
- Revenue
- BMEA N/A
- AKYA $86,815,000.00
- Revenue This Year
- BMEA N/A
- AKYA N/A
- Revenue Next Year
- BMEA N/A
- AKYA $11.76
- P/E Ratio
- BMEA N/A
- AKYA N/A
- Revenue Growth
- BMEA N/A
- AKYA N/A
- 52 Week Low
- BMEA $3.61
- AKYA $1.88
- 52 Week High
- BMEA $20.21
- AKYA $6.31
- Technical
- Relative Strength Index (RSI)
- BMEA 42.32
- AKYA 63.45
- Support Level
- BMEA $3.78
- AKYA $2.59
- Resistance Level
- BMEA $4.29
- AKYA $3.10
- Average True Range (ATR)
- BMEA 0.30
- AKYA 0.25
- MACD
- BMEA 0.15
- AKYA 0.04
- Stochastic Oscillator
- BMEA 89.71
- AKYA 65.52
About BMEA Biomea Fusion Inc.
Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.
About AKYA Akoya BioSciences Inc.
Akoya Biosciences Inc is a life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery, clinical research and diagnostics. Its PhenoCycler (formerly CODEX) and PhenoImager (formerly Phenoptics) platforms, reagents, software, and services, It offer end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research and diagnostics.